M
Medrhythms
Digital therapeutics company that uses sensors, music, and software to build evidence-based, neurologic interventions to measure and improve walking
About Medrhythms
MedRhythms is a pioneering company in the field of neurotherapeutics, focusing on the development of advanced solutions to improve walking, mobility, and related functional outcomes for individuals with neurologic injuries and diseases. The company operates in the healthcare and medical technology market, serving patients who suffer from persistent walking deficits and other movement disorders. MedRhythms employs a proprietary, patented technology platform that combines sensors, software, and music with advanced neuroscience to target neural circuitry and enhance brain health. The business model revolves around the creation and distribution of these innovative therapeutic solutions, generating revenue through the sale of their technology and services to healthcare providers and patients. Headquartered in Portland, Maine, MedRhythms has a hybrid workforce with employees located across the United States, all dedicated to the company's mission of improving the lives of those affected by neurologic conditions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Portland, United States
- Employees
- 60
- Open positions
- 2
- Dealroom signal
- 83.1/100
- Industry
- Health, Music
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Music, Data Analytics, Neurology, Digital Therapeutics, Hard Tech
- Business model
- SaaS
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Apr 2025 | $0 | — | Community Development Venture Capital Alliance | ↗ |
| LATE VCOther financing | Dec 2023 | $19M | $76M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Medrhythms is 3.8K monthly website visits, up 22.6% over the last three months. Medrhythms's team grew 3.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Jean Hoffman
Peter Werth
Morningside
Werth Family Investment Associates
Global Brain Corporation- BVBose Ventures
Series B and later3 investors entered at this stage
Maine Technology Institute
Advantage Capital
Community Development Venture Capital Alliance
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medrhythms on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medrhythms’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.